{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:16:05Z","timestamp":1753892165644,"version":"3.41.2"},"reference-count":28,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T00:00:00Z","timestamp":1690502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p><jats:bold>Background:<\/jats:bold> An estimate of 90% effective dose (ED90) of oxytocin infusion has already been proved effective in non-laboring parturients. However, the requirements of oxytocin for elderly parturients with prior history of cesarean delivery (CD) may be higher. The aim of this study was to find the optimum oxytocin infusion rate for preventing uterine atony during CD in elderly parturients with prior history of CD.<\/jats:p><jats:p><jats:bold>Method:<\/jats:bold> We performed a randomized, double-blinded study in 120 healthy elderly parturients with prior history of CD scheduled for elective CD under combined spinal\u2013epidural (CSE) anesthesia. Participants were treated with oxytocin infusion randomly at the rates of 0, 4, 8, 12, 16, or 20\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup> after the delivery of infants. Following oxytocin administration, a blinded obstetrician evaluated the uterine tone (UT), verbally describing it using numerical scales (0\u201310: 0, no UT; 10, optimal UT) as either adequate or inadequate at the time intervals of 3, 6, and 9\u00a0min. Maternal adverse effects, requirements for additional uterotonic agents, delivery\u2013placenta delivery time (PD), and estimated blood loss (EBL) were recorded.<\/jats:p><jats:p><jats:bold>Results:<\/jats:bold> The 50% effective dose (ED50) and 90% effective dose (ED90) of oxytocin infusion were 14.6\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup> (95% confidence interval 12.0\u201318.4\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup>) and 27.7\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup> (95% confidence interval 22.5\u201339.4\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup>), respectively. As the rate of infusion was increased in parturients, the rescue oxytocin dose and delivery-PD time were decreased. Parturients who received 0\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup> oxytocin at 3, 6, and 9\u00a0min obtained lower UT scores than those who received 16 and 20\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup> oxytocin (<jats:italic>p<\/jats:italic> &amp;lt; 0.05, respectively). No significant differences were observed among groups in EBL and maternal adverse effects.<\/jats:p><jats:p><jats:bold>Conclusion:<\/jats:bold> The infusion rate of oxytocin at 14.57 and 27.74\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup> produces adequate UT in 50% and 90% of elderly parturients with prior history of CD, respectively. An oxytocin infusion rate of 27.7\u00a0IU\u00a0h<jats:sup>\u22121<\/jats:sup> is suggested to be the optimal dose for preventing uterine atony during CD in elderly parturients with prior history of cesarean delivery.<\/jats:p><jats:p><jats:bold>Clinical Trial Registration:<\/jats:bold> [<jats:ext-link>https:\/\/www.chictr.org.cn\/bin\/project\/edit?pid=62489<\/jats:ext-link>], Identifier: [ChiCTR2000038891].<\/jats:p>","DOI":"10.3389\/fphar.2023.1211693","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T12:57:37Z","timestamp":1690549057000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The optimal oxytocin infusion rate for preventing uterine atony during cesarean delivery in elderly parturients with prior history of cesarean delivery"],"prefix":"10.3389","volume":"14","author":[{"given":"Li Ying","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ze Peng","family":"Ping","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin Zhong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chang Na","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,28]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"102","DOI":"10.4103\/japtr.JAPTR_297_18","article-title":"A comparative study on infusion of usual dose of oxytocin and 80 units dose of oxytocin in the prevention of postpartum hemorrhage in cesarean section","volume":"9","author":"Ahmadi","year":"2018","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"B2","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.3390\/ijerph18095029","article-title":"Prophylactic dose of oxytocin for uterine atony during caesarean delivery: A systematic review","volume":"18","author":"Baliuliene","year":"2021","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.1016\/0002-9378(95)91409-9","article-title":"Underappreciated risks of the elderly multipara","volume":"172","author":"Bobrowski","year":"1995","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.ijgo.2008.05.004","article-title":"Effect of parity and advanced maternal age on obstetric outcome","volume":"102","author":"Chan","year":"2008","journal-title":"Int. J. Gynaecol. Obstet."},{"key":"B5","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1097\/AOG.0000000000002351","article-title":"Practice bulletin No. 183: Postpartum hemorrhage","volume":"30","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/anae.14944","article-title":"Carbetocin at elective caesarean section: A sequential allocation trial to determine the minimum effective dose in obese women","volume":"75","author":"Drew","year":"2020","journal-title":"Anaesthesia"},{"key":"B7","doi-asserted-by":"publisher","first-page":"12305","DOI":"10.14814\/phy2.12305","article-title":"Maternal age effects on myometrial expression of contractile proteins, uterine gene expression, and contractile activity during labor in the rat","volume":"3","author":"Elmes","year":"2015","journal-title":"Physiol. Rep."},{"key":"B8","doi-asserted-by":"publisher","first-page":"578","DOI":"10.1007\/s12630-010-9297-1","article-title":"Up-down determination of the ED(90) of oxytocin infusions for the prevention of postpartum uterine atony in parturients undergoing Cesarean delivery","volume":"57","author":"George","year":"2010","journal-title":"Can. J. Anaesth."},{"key":"B9","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1055\/s-0036-1592130","article-title":"Intravenous oxytocin use to decrease blood loss during scheduled cesarean delivery: A randomized double-blinded controlled trial (oxytrial)","volume":"34","author":"Ghulmiyyah","year":"2017","journal-title":"Am. J. Perinatol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1111\/anae.14757","article-title":"International consensus statement on the use of uterotonic agents during caesarean section","volume":"74","author":"Heesen","year":"2019","journal-title":"Anaesthesia"},{"key":"B11","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/j.1471-0528.2009.02356.x","article-title":"ST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial","volume":"117","author":"Jonsson","year":"2010","journal-title":"BJOG"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1080\/01443615.2019.1606172","article-title":"Effect of advanced maternal age on pregnancy outcomes: A single-centre data from a tertiary healthcare hospital","volume":"39","author":"Kanmaz","year":"2019","journal-title":"J. Obstet. Gynaecol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3109\/14767058.2013.807240","article-title":"Advanced maternal age and postpartum hemorrhage - risk factor or red herring?","volume":"27","author":"Lao","year":"2014","journal-title":"J. Matern. Fetal Neonatal Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1213\/ANE.0000000000000781","article-title":"The ED90 of prophylactic oxytocin infusion after delivery of the placenta during cesarean delivery in laboring compared with nonlaboring women: An up-down sequential allocation dose-response study","volume":"121","author":"Lavoie","year":"2015","journal-title":"Anesth. Analg."},{"key":"B15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1111\/1471-0528.14291","article-title":"VBAC should be encouraged as a means to reduce the caesarean section rate in China: For: VBAC reduces not only the caesarean section rate but also other associated issues","volume":"123","author":"Ma","year":"2016","journal-title":"BJOG"},{"key":"B16","first-page":"1","article-title":"First births to older women continue to rise","volume":"152","author":"Matthews","year":"2014","journal-title":"NCHS Data Brief."},{"key":"B17","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1080\/01443615.2020.1780421","article-title":"Comparison of the benefits and hemodynamic side effects of oxytocin between intravenous infusion with and without bolus injection during caesarean section","volume":"41","author":"Miyoshi","year":"2021","journal-title":"J. Obstet. Gynaecol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/s0029-7844(01)01479-x","article-title":"Comparison of two oxytocin regimens to prevent uterine atony at cesarean delivery: A randomized controlled trial","volume":"98","author":"Munn","year":"2001","journal-title":"Obstet. Gynecol."},{"key":"B19","unstructured":"Births in England and wales: 20182018"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1113\/JP273350","article-title":"Effect of reproductive ageing on pregnant mouse uterus and cervix","volume":"595","author":"Patel","year":"2017","journal-title":"J. Physiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"250.1","DOI":"10.1016\/j.ajog.2021.04.258","article-title":"Intravenous oxytocin dosing regimens for postpartum hemorrhage prevention following cesarean delivery: A systematic review and meta-analysis","volume":"225","author":"Phung","year":"2021","journal-title":"Am. J. Obstet. Gynecol."},{"key":"B22","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12884-019-2692-x","article-title":"The ED50 and ED95 of oxytocin infusion rate for maintaining uterine tone during elective caesarean delivery: A dose-finding study","volume":"20","author":"Qian","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"B23","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1055\/s-0032-1329184","article-title":"Dose and duration of oxytocin to prevent postpartum hemorrhage: A review","volume":"30","author":"Roach","year":"2013","journal-title":"Am. J. Perinatol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1371\/journal.pmed.0050144","article-title":"The effect of delaying childbirth on primary cesarean section rates","volume":"5","author":"Smith","year":"2008","journal-title":"PLoS Med."},{"key":"B25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1093\/bja\/ael302","article-title":"Haemodynamic effects of oxytocin given as i.v. bolus or infusion on women undergoing Caesarean section","volume":"98","author":"Thomas","year":"2007","journal-title":"Br. J. Anaesth."},{"key":"B26","doi-asserted-by":"publisher","first-page":"5451","DOI":"10.2147\/DDDT.S258651","article-title":"The median effective dose of oxytocin needed to prevent uterine atony during cesarean delivery in elderly parturients","volume":"14","author":"Wei","year":"2020","journal-title":"Drug Des. Devel Ther."},{"key":"B27","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1007\/s40261-021-01090-x","article-title":"The intraoperative median effective dose of oxytocin for preventing uterine atony in parturients with a prior history of caesarean delivery","volume":"41","author":"Wei","year":"2021","journal-title":"Clin. Drug Investig."},{"key":"B28","doi-asserted-by":"publisher","first-page":"e7905","DOI":"10.1097\/MD.0000000000007905","article-title":"Abdominal girth and vertebral column length aid in predicting intrathecal hyperbaric bupivacaine dose for elective cesarean section","volume":"96","author":"Wei","year":"2017","journal-title":"Med. Baltim."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1211693\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T12:57:40Z","timestamp":1690549060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2023.1211693\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,28]]},"references-count":28,"alternative-id":["10.3389\/fphar.2023.1211693"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2023.1211693","relation":{},"ISSN":["1663-9812"],"issn-type":[{"type":"electronic","value":"1663-9812"}],"subject":[],"published":{"date-parts":[[2023,7,28]]},"article-number":"1211693"}}